The UNC Blood Research Center (BRC) was established to promote interdisciplinary research in non-malignant blood disorders across UNC. It will seek to advance the work in the following specific areas.
One in four of the US population will succumb to a terminal thrombotic event, such as: myocardial infarction, stroke, or venous thromboembolism.
Basic science discoveries have paved the way towards better prophylactic and therapeutic approaches to thrombosis. However, a better understanding of the mechanisms underlying thrombosis and prevention without any risk of bleeding remains an unmet need. The BRC seeks to investigate potential approaches to both aims.
UNC is a world leader in hemophilia, from the development and administration of the first coagulation factor VIII concentrate to the role of the Chapel Hill dog colonies of the Francis Owen Blood Research Center in the pre-clinical testing of protein and gene therapies. The BRC aims to address the broad challenges that remain in numerous other inherited and acquired bleeding disorders.
Sickle cell disease affects approximately 100,000 Americans but accounts for an estimated 300,000 births worldwide every year, primarily in sub-Saharan Africa and the Indian sub-continent.
Compared to many other areas of medicine, the development of impactful therapies in sickle cell disease remains inadequate. We will continue to expand our research efforts to this under-served patient population into the future.
Tuesday 9:00 am
Tuesday 9:00 am
Friday 11:00 am
Tuesday 9:00 am
3 weeks ago
Swati Sharma has been awarded an Early Career Travel Award to attend the ISTH meeting in Washington, DC, June 21-25, 2025. Each year, the ISTH Congress Scientific Committee rewards abstracts of outstanding quality and provides the submitting author with a Travel Award to attend the ISTH Congress. Three categories of Travel Award are distributed: Early …
3 weeks ago
Alisa S. Wolberg, Ph.D. gave The Dr. William Bell Lecture in Hematology at Johns Hopkins University March 31, 2025. Dr. Wolberg’s lecture was entitled “Venous thromboembolism: fibrinogen, factor XIII, and new potential targets.” Dr. William R. Bell (1935-2013) was an internationally acclaimed hematologist and a professor and researcher at The Johns Hopkins Hospital. During Dr. …
3 weeks ago
Ana Sachetto, PhD, is now a co-chair of the International Postdoc Alliance of the UNC Postdoctoral Association. The University of North Carolina Postdoctoral Association (PDA) is a peer-led volunteer organization dedicated to addressing the needs and concerns of all UNC postdocs. PDA works closely with the Office of Postdoctoral Affairs to provide resources for professional development, generate …